2024 annual financial data
Rhythm Pharmaceuticals 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was -87.51%.
Operating income was -265,503,000 USD and net income was -260,602,000 USD.
Operating cash flow was -113,879,000 USD.
Get free Rhythm Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 130,126,000 USD
- Operating income
- -265,503,000 USD
- Net income
- -260,602,000 USD
- Operating cash flow
- -113,879,000 USD